Skip to main content
. 2022 Jun 23;13:898493. doi: 10.3389/fimmu.2022.898493

Figure 2.

Figure 2

IGFBP7 expression and clinicopathological features in BLCA. (A–C) High T stage, high pathologic stage and non-papillary subtype were associated with higher expressions of IGFBP7 in BLCA. (D–F) No statistically significant differences were found between the expression levels of IGFBP7 in BLCA and N stage, lymphovascular invasion and histologic grade. **p < 0.01; ***p < 0.001; ns, no significance.